cat 2003
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01725594)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109320 ↗
Also known as
- cat 2003
- cat-2003
- cat-203
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02098278 | Phase 2 | Mar 1, 2014 | Catabasis |
| NCT01968720 | Phase 2 | Oct 1, 2013 | Catabasis |
| NCT01912560 | Phase 2 | Jul 1, 2013 | Catabasis |
| NCT01725594 | Phase 1 | Nov 1, 2012 | Catabasis, Medpace, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catabasis | For profit | 4 | 4 | 2 | 2012 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1